A new scientific experiment from University of Copenhagen shows that soccer is better for your health than jogging. Researchers believe that soccer can be used to actively fight obesity. Soccer is not just a game of fun. The research shows that a game of soccer two to three times a week is profoundly health-improving. As a matter of fact, the beneficial effects are so massive that it beats jogging.
A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer’s disease.
In a study of children and adolescents with hypertension, only about one in four had been previously diagnosed with the condition, according to a study in the Aug. 22/29 issue of JAMA.
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer, researchers have found in a laboratory study that will be reported today at the 234th national meeting of the American Chemical Society.
A new study looking at the relationship between vitamin D serum levels and the risk of colon and breast cancer across the globe has estimated the number of cases of cancer that could be prevented each year if vitamin D3 levels met the target proposed by researchers.
A review of previous research suggests that prominent claims of sex differences of gene-disease associations are often insufficiently documented and validated, according to an article in the Aug. 22/29 issue of JAMA.
Experts at the University are studying an illness known as HAPE (high altitude pulmonary oedema), which causes fluid to build up in the lungs can and can occur from as low as 2,500 metres, affecting people of all age groups and fitness levels.
Non-medicinal interventions are highly effective in preventing the behavioral and academic problems associated with Attention Deficit Hyperactivity Disorder (ADHD), according to a five-year study led by researchers at Lehigh University?s College of Education.
Groundbreaking research from the University of Melbourne has shed new light on why long term drug users find it hard to say no, despite dire consequences to their health.
Reclast (zoledronic acid) Injection — the first and only once-yearly medicine for postmenopausal osteoporosis — has been approved by the US Food and Drug Administration FDA.